Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06158412
What this trial is testing

All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
The First Affiliated Hospital of Xiamen University 25
Early research (Phase 1)Study completedNCT02920697
What this trial is testing

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)B-Cell Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)
Institut de Recherches Internationales Servier 65
Early research (Phase 1)Ended earlyNCT04895410
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527340
What this trial is testing

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 140
Large-scale testing (Phase 3)UnknownNCT03385096
What this trial is testing

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Who this might be right for
Autologous Hematopoietic Stem Cell TransplantationConditioningMultiple Myeloma
Nanfang Hospital, Southern Medical University 122
Early research (Phase 1)Ended earlyNCT04730505
What this trial is testing

Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM

Who this might be right for
Multiple Myeloma
Celgene 2
Testing effectiveness (Phase 2)Study completedNCT01237054
What this trial is testing

Imaging in MGUS, SMM and MM

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00320476
What this trial is testing

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 35
Early research (Phase 1)Study completedNCT01114282
What this trial is testing

Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

Who this might be right for
Multiple Myeloma
Stanford University 11
Not applicableStudy completedNCT05565391
What this trial is testing

Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 508
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)UnknownNCT03792620
What this trial is testing

Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation

Who this might be right for
Multiple Myeloma Stage I
Grupo de Estudos Multicentricos em Onco-Hematologia 20
Testing effectiveness (Phase 2)Study completedNCT02272803
What this trial is testing

Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 82
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Large-scale testing (Phase 3)UnknownNCT00998270
What this trial is testing

Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Tehran University of Medical Sciences 185
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789522
What this trial is testing

Safety and Efficacy of Elranatamab Plus Isatuximab, Bortezomib, and Lenalidomide in Ultra-High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07107204
What this trial is testing

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed or Refractory Hematologic MalignanciesLeukemiaLymphoma+1 more
Biotroy Therapeutics 116
Not applicableStudy completedNCT03001804
What this trial is testing

Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients

Who this might be right for
Multiple Myeloma
Celgene 29
Testing effectiveness (Phase 2)Looking for participantsNCT07116616
What this trial is testing

MRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
ModernaTX, Inc. 190
Early research (Phase 1)Study completedNCT00446342
What this trial is testing

Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

Who this might be right for
B-lymphoid MalignanciesChronic Lymphocytic LeukemiaMantle Cell Lymphoma+1 more
Sunesis Pharmaceuticals 21
Next Page